|
|
Volumn 6, Issue 2, 2002, Pages 95-102
|
|
A clinical evaluation of tazarotene 0.1% Gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETAMETHASONE DIPROPIONATE;
CORTICOSTEROID;
DIFLORASONE DIACETATE;
FLUOCINONIDE;
FLUTICASONE PROPIONATE;
MOMETASONE FUROATE;
TAZAROTENE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREAM;
DRUG EFFICACY;
DRUG POTENCY;
DRUG TOLERABILITY;
ERYTHEMA;
FEMALE;
GEL;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
OINTMENT;
PATIENT SATISFACTION;
PRIORITY JOURNAL;
PRURITUS;
PSORIASIS;
RANDOMIZED CONTROLLED TRIAL;
SINGLE BLIND PROCEDURE;
SKIN IRRITATION;
TREATMENT OUTCOME;
ADMINISTRATION, TOPICAL;
ANTI-INFLAMMATORY AGENTS;
DRUG THERAPY, COMBINATION;
GELS;
GLUCOCORTICOIDS;
HUMANS;
KERATOLYTIC AGENTS;
NICOTINIC ACIDS;
PATIENT SATISFACTION;
PSORIASIS;
TREATMENT OUTCOME;
|
|
EID: 0036262295
PISSN: 12034754
EISSN: None
Source Type: Journal
DOI: 10.1007/s10227-001-0031-z Document Type: Article |
|
Times cited : (46)
|
|
References (6)
|
